RTSM Solutions for Phase 2 Trials - Medical / Health Care
Prancer RTSM provides the flexibility you need to explore all the possible paths for determining the optimal dose, patient population, and combination therapies within your Phase 2 trials.
Prancer RTSM? is 100% configurable, allowing you to build flexibility into the study design upfront and enable efficient protocol amendments as you follow the science. By adding countries, activating new cohorts, or choosing dose levels, Prancer RTSM? enables you to experiment until you achieve the desired result.
Clinical trials with unpredictable demand present unique challenges when it comes to reducing waste and preventing stock-out. Prancer RTSM? has a fully integrated forecasting engine, allowing you to make business decisions without having a degree in statistics.